ReviewFrontiers in chemistry2014
Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments.
Charlene M Dawidczyk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this papertrialcites it